Dianthus Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 463K | 284K | 396K | 193K | 1.2M | 1.3M | 2.2M | 1.9M |
| Cost of Goods Sold | 76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 387K | 284K | 396K | 193K | 1.2M | 1.3M | 2.2M | 1.9M |
| R&D Expenses | 34.5M | 59.9M | 32.5M | 26.3M | 27.0M | 26.4M | 25.5M | 18.1M |
| Operating Expenses | 46.9M | 69.8M | 40.7M | 35.1M | 34.3M | 33.2M | 32.1M | 24.1M |
| Operating Income | -46.5M | -69.5M | -40.3M | -34.9M | -33.2M | -31.9M | -29.9M | -22.2M |
| Other Income / Gains | 5.7M | 167.4M | 3.5M | 3.3M | 3.7M | 3.5M | 4.7M | 4.6M |
| Net Income | -40.8M | 97.9M | -36.8M | -31.6M | -29.5M | -28.4M | -25.2M | -17.6M |
| EPS (Diluted) | -0.85 | 2.59 | -0.97 | -0.88 | -0.82 | -0.81 | -0.74 | -0.51 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.836 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 12.5M | 9.9M | 8.2M | 8.9M | 7.3M | 6.8M | 6.5M | 6.0M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 12.5M | 9.9M | 8.2M | 8.9M | 7.3M | 6.8M | 6.5M | 6.0M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 47.0M | 69.8M | 40.7M | 35.1M | 34.3M | 33.2M | 32.1M | 24.1M |
| Interest Income | 6.3M | 5.3M | 3.7M | 3.4M | 3.8M | 4.0M | 4.4M | 4.7M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 76K | 259K | 27K | 99K | 133K | 78K | 116K | 111K |
| Ebitda | -46.5M | -69.3M | -36.7M | -34.8M | -33.0M | -31.8M | -29.8M | -22.1M |
| Ebitdaratio | -100.503 | -243.951 | -92.773 | -180.456 | -28.413 | -24.011 | -13.713 | -11.859 |
| Operating Income Ratio | -100.503 | -244.863 | -101.737 | -180.969 | -28.527 | -24.069 | -13.766 | -11.918 |
| Income Before Tax | -40.8M | 97.9M | -36.8M | -31.6M | -29.5M | -28.4M | -25.2M | -17.6M |
| Income Before Tax Ratio | -88.194 | 344.736 | -92.841 | -163.881 | -25.375 | -21.448 | -11.59 | -9.451 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -88.194 | 344.736 | -92.841 | -163.881 | -25.375 | -21.448 | -11.59 | -9.451 |
| Epsdiluted | -0.85 | 2.59 | -0.97 | -0.88 | -0.82 | -0.81 | -0.74 | -0.51 |
| Weighted Average Shs Out | 48.0M | 37.8M | 37.8M | 35.8M | 35.8M | 35.0M | 34.2M | 34.2M |
| Weighted Average Shs Out Dil | 48.0M | 37.8M | 37.8M | 35.8M | 35.8M | 35.0M | 34.2M | 34.2M |